We are live on ! Find out more
VVA

Vida Ventures Advisors Portfolio holdings

AUM $29.4M
1-Year Est. Return 93.58%
This Fund
S&P 500
This Quarter Est. Return
-24.31%
1 Year Est. Return
+93.58%
3 Year Est. Return
+153.74%
5 Year Est. Return
+14.63%
10 Year Est. Return
–
AUM
$267M
AUM Growth
-$81.8M
Cap. Flow
+$18.5M
Cap. Flow %
6.91%
Top 10 Hldgs %
100%
Holding
9
New
1
Increased
–
Reduced
–
Closed
1

Top Buys

Rank Stock Value
1
LIAN
LianBio American Depositary Shares
LIAN
+$26.1M

Top Sells

Rank Stock Value
1
OYST
Oyster Point Pharma, Inc. Common Stock
OYST
+$7.58M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRAX icon
1
Praxis Precision Medicines
PRAX
$8.8B
$57.9M 21.66%
195,955
– –
KNTE
2
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$48.7M 18.21%
2,747,433
– –
CNTA
3
DELISTED
Centessa Pharmaceuticals
CNTA
$44.3M 16.56%
3,931,818
– –
KRON
4
DELISTED
Kronos Bio
KRON
$37.6M 14.06%
2,765,314
– –
DYN icon
5
Dyne Therapeutics
DYN
$4.24B
$35.2M 13.17%
2,960,046
– –
ALLO icon
6
Allogene Therapeutics
ALLO
$604M
$26.8M 10.04%
1,798,163
– –
LIAN
7
DELISTED
LianBio American Depositary Shares
LIAN
$14.1M 5.26%
+2,282,084
New +$26.1M
QTTB icon
8
Q32 Bio
QTTB
$452M
$2.81M 1.05%
42,825
– –
OYST
9
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
– –
-640,070
Closed -$7.58M

Similar funds

NC
Nucleo Capital Sao Paulo, Sp, Brazil $29.1M AUM 59.16% 1-Year Est. Return
PIM
Pinnacle Investment Management Hong Kong $28.9M AUM 32% 1-Year Est. Return
NCPI
NewView Capital Partners I Burlingame, California $28M AUM 10.55% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
RE
ROB Exploration New York $27.3M AUM 13.99% 1-Year Est. Return
VM
Valinor Management New York $32.2M AUM 44.16% 1-Year Est. Return
BCA
Burren Capital Advisors Gibraltar $33M AUM 47.67% 1-Year Est. Return
VCM
Vector Capital Management San Francisco, California $24.4M AUM 14.95% 1-Year Est. Return

Vida Ventures Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Vida Ventures Advisors held 9 positions worth $267M, down 23% from $349M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Vida Ventures Advisors deployed $18.5M of net new capital in Q4 2021, opening 1 new position. Its largest new stake was LianBio American Depositary Shares: 2,282,084 shares worth $14.1M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

On the sell side, the most notable exit was Oyster Point Pharma, Inc. Common Stock, an estimated $7.58M sold.

  • Vida Ventures Advisors's largest Q4 2021 buy was LianBio American Depositary Shares: 2,282,084 shares worth $14.1M.
  • Vida Ventures Advisors fully exited Oyster Point Pharma, Inc. Common Stock in Q4 2021, selling an estimated $7.58M.
  • Vida Ventures Advisors's ten largest holdings make up 100% of its $267M portfolio in Q4 2021.
  • Vida Ventures Advisors opened 1 new position and closed 1 in Q4 2021.
  • Vida Ventures Advisors's portfolio value fell 23% quarter-over-quarter to $267M.

Based on Vida Ventures Advisors's 13F filing for Q4 2021, filed 10 Feb 2022.